Samsung Group said it has won approval from regulators to sell a near-replica of the blockbuster rheumatoid arthritis drug Enbrel in Europe.
Baca Berita Asal
Bagikan Berita Ini
Monday, January 18, 2016
Tech
Samsung Gets European Approval for Enbrel Copy
Samsung Gets European Approval for Enbrel Copy
Samsung Group said it has won approval from regulators to sell a near-replica of the blockbuster rheumatoid arthritis drug Enbrel in Europe.
Baca Berita Asal
Bagikan Berita Ini
Samsung Group said it has won approval from regulators to sell a near-replica of the blockbuster rheumatoid arthritis drug Enbrel in Europe.
Baca Berita Asal
Bagikan Berita Ini
0 Response to "Samsung Gets European Approval for Enbrel Copy"
Post a Comment